Asahi Intecc07.16.18
Asahi Intecc Group announced that its Board of Directors’ meeting held on July 6, 2018 passed a resolution that ASAHI INTECC USA Inc., a 100 percent subsidiary of Asahi Intecc, would acquire shares of RetroVascular Inc. and make RetroVascular its subsidiary (sub-subsidiary of Asahi Intecc).
RetroVascular Inc. (Retro) is an R&D-type company in the United States that has been promoting research and development related to new treatment methods in the PTCA treatment and new medical devices suitable to such treatment methods through cooperation with physicians.
Retro and Asahi Intecc Group have been maintaining collaborative relationship in the development used for PTCA treatment products. In recent years, Retro has been also working on the development of plasma energy technology using electrical energy aiming at further improvement of treatment results in the PTCA treatment and is in the process of establishing the basic technology.
Through fusion of Retro’s plasma energy technology with technologies owned by Asahi Intecc Group, it is possible to realize innovative medical devices leading to the improvement of treatment results in the CTO area in the future. In addition, the realization would make it possible to contribute to the acceleration of shift to PTCA treatment from surgery in the CTO area. Further, these technologies are expected to be used in wide areas not limited to cardiovascular system areas but also to occlusion of the peripheral vascular system areas.
Moreover, in addition to these technological factors, Asahi Intecc Group believes that it is possible to use Retro as the base for gathering and surveying advanced information because the company is based in Silicon Valley in California, which is the center of cutting-edge and advanced medical device innovation in the world. Therefore, Asahi Intecc has adopted a resolution to acquire Retro’s shares in view of these factors.
By making Retro a company of Asahi Intecc Group through the acquisition of its shares, fusion of both companies’ technologies will be evolved and developed further, which would promote the enhancement of a technological foundation of Asahi Intecc Group as an R&D-type company, leading to further improvement of the corporate value.
RetroVascular Inc. (Retro) is an R&D-type company in the United States that has been promoting research and development related to new treatment methods in the PTCA treatment and new medical devices suitable to such treatment methods through cooperation with physicians.
Retro and Asahi Intecc Group have been maintaining collaborative relationship in the development used for PTCA treatment products. In recent years, Retro has been also working on the development of plasma energy technology using electrical energy aiming at further improvement of treatment results in the PTCA treatment and is in the process of establishing the basic technology.
Through fusion of Retro’s plasma energy technology with technologies owned by Asahi Intecc Group, it is possible to realize innovative medical devices leading to the improvement of treatment results in the CTO area in the future. In addition, the realization would make it possible to contribute to the acceleration of shift to PTCA treatment from surgery in the CTO area. Further, these technologies are expected to be used in wide areas not limited to cardiovascular system areas but also to occlusion of the peripheral vascular system areas.
Moreover, in addition to these technological factors, Asahi Intecc Group believes that it is possible to use Retro as the base for gathering and surveying advanced information because the company is based in Silicon Valley in California, which is the center of cutting-edge and advanced medical device innovation in the world. Therefore, Asahi Intecc has adopted a resolution to acquire Retro’s shares in view of these factors.
By making Retro a company of Asahi Intecc Group through the acquisition of its shares, fusion of both companies’ technologies will be evolved and developed further, which would promote the enhancement of a technological foundation of Asahi Intecc Group as an R&D-type company, leading to further improvement of the corporate value.
